ChartMill,,2019-05-21 13:24:00,3.324,NSPR has a bad technical rating but it does show a decent setup pattern chartmillcomanalyzephpu
bullrider_return,True,2019-05-21 13:23:00,3.324,NSPR bafanabafana were here for the investment news for CGuard 36 month trial study in EuroPCR which ends in May 2019 Just waiting on the positive news from the study of 251 patients in the trial study from 2016 Missed last years posiive update after 24 months study for safety efficacy and stroke free intervention in May 2018 I dont want to miss out on the end of the 36 month trial study which ends May of this year 2019 Plus the InspireMD submission of CGuard IDE Investigation Device Exemption in the US in mid 2019At least 2 great press release will be coming our way That imo will get the share price back over 8 or More
breaking_stocks,,2019-05-21 11:35:00,3.3,NSPR described at alphafinewscomearningsre
bafanabafana,,2019-05-21 11:13:00,3.3,NSPR and ppl will tell u about the low float and low valuation Fact is this will not have an impact as they run down the cash and go for another offering year after year just rinse and repeat
bafanabafana,,2019-05-21 11:06:00,3.3,NSPR just to put things into perdpective pre rs SP at its peak in May 2011 would be 497 m USD which means you lost since then 9999994 of your investments Since then this company carried out on average a 16 rs on a yearly basis You can check yourself how much the CEO put in his pocket during the last 8 years
JohnBju,True,2019-05-21 10:42:00,3.3,NSPR I like
Nate_V,True,2019-05-21 10:07:00,3.307,NSPR Yawn
playerzclub,,2019-05-21 09:46:00,3.23,NSPR were is the volume
stocktowatch7,,2019-05-21 09:42:00,3.239,NSPR here goes on stocksequitycomactivesto
